The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
H.R. 4981·119th Congress·Introduced Aug 15, 2025

Stamp Out Lyme Disease Act

IntroducedHealthSubstantive
View bill text
Sponsor
Rep. Gottheimer, Josh [D-NJ-5]
Committees
Energy and Commerce Committee (primary)
Last action
Aug 15, 2025

Bottom line

The bill creates a voluntary public funding mechanism for Lyme disease research through the sale of a special postage stamp, aiming to increase research funds without impacting existing federal appropriations.

What it actually does

This bill mandates the United States Postal Service (USPS) to issue a "Lyme Disease Research Semipostal Stamp." The proceeds from the sale of this stamp, beyond the regular postage cost, will be transferred to the National Institute of Allergy and Infectious Diseases (NIAID) to fund research into Lyme disease and related tick-borne illnesses. The stamp is required to be available for purchase for a minimum of six years.

Proponents argue

Proponents argue this bill provides a simple, voluntary, and effective way for the public to contribute to critical Lyme disease research. They highlight the significant public health burden and economic cost of Lyme disease, emphasizing the urgent need for more funding for improved diagnosis, treatment, and understanding of persistent symptoms. The semipostal stamp mechanism allows individuals to directly support a cause they care about without requiring new taxpayer appropriations.

Opponents contend

Opponents might argue that while the intent is good, semipostal stamps typically generate relatively small amounts of funding compared to the scale of the problem and the overall NIH budget, potentially creating a false sense of comprehensively addressing the issue. Some might also raise concerns about the administrative costs associated with issuing and managing such stamps, which could diminish the net proceeds for research.

The bill is exceptionally short and easy to read, allowing ample time for a thorough understanding of its provisions.

Section 2(b), Section 3(a)

Mandate for Lyme Disease Research Semipostal Stamp Issuance

prominently featuredstraightforward

This provision directs the U.S. Postal Service to create and sell a special postage stamp, known as a semipostal stamp, dedicated to Lyme disease research. A semipostal stamp is sold at a price higher than the cost of regular postage, with the additional amount typically going to a specific cause. This stamp is intended to provide a convenient way for the public to contribute to research efforts for Lyme disease and related tick-borne illnesses.

GroupImpactMechanismScale
GroupGeneral public/Stamp purchasersImpactProvides a voluntary opportunity to contribute to Lyme disease research.MechanismPurchase of a postage stamp at a slightly higher price than standard postage.ScaleIndividual choice, small financial impact per purchase.
GroupLyme disease patients and researchersImpactPotential for increased research funding to address diagnosis, treatment, and persistent symptoms.MechanismProceeds from stamp sales are directed to NIAID for research.ScaleIndirect benefit, dependent on the volume of stamp sales.

Supporters argue

Supporters argue this provision offers a unique and accessible avenue for public engagement and fundraising for a critical health issue. It leverages the widespread use of postal services to generate awareness and funds without imposing new taxes or mandatory spending.

Critics contend

Critics might suggest that relying on voluntary stamp purchases for research funding is an insufficient and potentially unreliable mechanism for addressing a significant public health challenge, arguing that more substantial and consistent federal appropriations are needed.

Tradeoffs

The tension lies between providing a voluntary funding option and the potential for it to be seen as a substitute for more robust, direct federal funding. It balances public engagement with the scale of the funding needed for a widespread health issue.

Section 3(b)

Allocation of Funds to NIAID and Protection from Funding Offsets

prominently featuredstraightforward

This section specifies that all funds generated from the sale of the Lyme Disease Research Semipostal Stamp, beyond the standard postage value, will be transferred to the National Institute of Allergy and Infectious Diseases (NIAID) for Lyme disease and related tick-borne illness research. Crucially, it also states that these funds cannot be used to reduce or offset other federal appropriations or funding levels for NIAID, ensuring that the stamp proceeds represent additional, supplemental funding.

Section 3(c)

Minimum Six-Year Availability Period

mentioned in summarystraightforward

This provision mandates that the Lyme Disease Research Semipostal Stamp must be made available to the public for a minimum period of six years. Furthermore, the issuance of the stamp must begin no later than 12 months after the date the bill is enacted into law. This ensures a sustained period for public contribution and fundraising, allowing for long-term awareness and revenue generation.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
  • Follow the money
  • Critical analysis
  • Questions to ask
Ask Ledger AI about this